Valuation: Perrigo Company plc

Market Cap 141.41Cr 425.17Cr 123.69Cr 114.09Cr 105.37Cr 199.95Cr 13TCr 203.31Cr 1.36TCr 535.33Cr 6.64TCr 530.96Cr 519.41Cr 23TCr P/E 2026 *
-73x
P/E 2027 * 8.81x
Enterprise Value 435.31Cr 1.31TCr 380.77Cr 351.21Cr 324.38Cr 615.5Cr 42TCr 625.85Cr 4.2TCr 1.65TCr 20TCr 1.63TCr 1.6TCr 70TCr EV / Sales 2026 *
1.07x
EV / Sales 2027 * 1.04x
Free-Float
99.61%
Yield 2026 *
11.3%
Yield 2027 * 11.6%
Manager TitleAgeSince
Chief Executive Officer 63 07/06/2026
Director of Finance/CFO 51 16/05/2022
Chief Operating Officer - 23/06/2025
Director TitleAgeSince
Director/Board Member 75 01/11/2014
Director/Board Member 61 07/11/2016
Director/Board Member 70 06/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%-2.55% - - 141.41Cr
-2.33%-2.09%+50.33%+162.29% 1,06000Cr
-0.82%-2.30%+62.97%+61.11% 62TCr
-0.73%-4.98%+27.22%+84.46% 44TCr
+0.33%-1.17%+27.98%+26.90% 33TCr
-0.02%-2.85%+25.27%+44.88% 28TCr
-3.89%-11.22%+20.78%+26.07% 27TCr
+0.66%-1.42%-29.26%-39.30% 22TCr
-0.06%-2.88%+20.98%+61.70% 20TCr
-3.72%-1.10%+13.35%+71.53% 16TCr
Average -0.77%-3.25%+24.40%+55.51% 39.71TCr
Weighted average by Cap. -0.56%-2.96%+35.28%+81.27%

Financials

2026 *2027 *
Net sales 405.62Cr 1.22TCr 354.8Cr 327.26Cr 302.26Cr 573.52Cr 39TCr 583.17Cr 3.91TCr 1.54TCr 19TCr 1.52TCr 1.49TCr 66TCr 409.85Cr 1.23TCr 358.49Cr 330.66Cr 305.4Cr 579.49Cr 39TCr 589.24Cr 3.95TCr 1.55TCr 19TCr 1.54TCr 1.51TCr 66TCr
Net income -34Cr -101.92Cr -30Cr -27Cr -25Cr -48Cr -3.23TCr -49Cr -326.79Cr -128.33Cr -1.59TCr -127.28Cr -124.51Cr -5.48TCr 16Cr 49Cr 14Cr 13Cr 12Cr 23Cr 1.54TCr 23Cr 155.59Cr 61Cr 758.33Cr 61Cr 59Cr 2.61TCr
Net Debt 293.9Cr 883.64Cr 257.07Cr 237.12Cr 219Cr 415.55Cr 28TCr 422.54Cr 2.83TCr 1.11TCr 14TCr 1.1TCr 1.08TCr 47TCr 282.8Cr 850.27Cr 247.37Cr 228.16Cr 210.73Cr 399.86Cr 27TCr 406.58Cr 2.73TCr 1.07TCr 13TCr 1.06TCr 1.04TCr 46TCr
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Trader
Investor
Global
Quality
ESG MSCI
BB